Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dengue virus life cycle: viral and host factors modulating infectivity.

Literature DB >> 20372965

Dengue virus life cycle: viral and host factors modulating infectivity.

Izabela A Rodenhuis-Zybert¹, Jan Wilschut, Jolanda M Smit.

Abstract

Dengue virus (DENV 1-4) represents a major emerging arthropod-borne pathogen. All four DENV serotypes are prevalent in the (sub) tropical regions of the world and infect 50-100 million individuals annually. Whereas the majority of DENV infections proceed asymptomatically or result in self-limited dengue fever, an increasing number of patients present more severe manifestations, such as dengue hemorrhagic fever and dengue shock syndrome. In this review we will give an overview of the infectious life cycle of DENV and will discuss the viral and host factors that are important in controlling DENV infection.

Entities: Disease Species

Mesh：

Substances：
Viral Proteins

Year: 2010 PMID： 20372965 DOI： 10.1007/s00018-010-0357-z

Source DB: PubMed Journal: Cell Mol Life Sci ISSN： 1420-682X Impact factor: 9.261

205 in total

1. Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?

Authors: H Loke; D B Bethell; C X Phuong; M Dung; J Schneider; N J White; N P Day; J Farrar; A V Hill
Journal: J Infect Dis Date: 2001-11-13 Impact factor: 5.226

2. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody.

Authors: Mickaël V Cherrier; Bärbel Kaufmann; Grant E Nybakken; Shee-Mei Lok; Julia T Warren; Beverly R Chen; Christopher A Nelson; Victor A Kostyuchenko; Heather A Holdaway; Paul R Chipman; Richard J Kuhn; Michael S Diamond; Michael G Rossmann; Daved H Fremont
Journal: EMBO J Date: 2009-08-27 Impact factor: 11.598

3. A prospective study of dengue infections in Bangkok.

Authors: D S Burke; A Nisalak; D E Johnson; R M Scott
Journal: Am J Trop Med Hyg Date: 1988-01 Impact factor: 2.345

4. Molecular and in vitro analysis of eight dengue type 2 viruses isolated from patients exhibiting different disease severities.

Authors: M N Mangada; A Igarashi
Journal: Virology Date: 1998-05-10 Impact factor: 3.616

5. Antibody-enhanced dengue virus infection in primate leukocytes.

Authors: S B Halstead; E J O'Rourke
Journal: Nature Date: 1977-02-24 Impact factor: 49.962

6. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes.

Authors: P Hilgard; R Stockert
Journal: Hepatology Date: 2000-11 Impact factor: 17.425

7. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission.

Authors: S B Halstead; T G Streit; J G Lafontant; R Putvatana; K Russell; W Sun; N Kanesa-Thasan; C G Hayes; D M Watts
Journal: Am J Trop Med Hyg Date: 2001-09 Impact factor: 2.345

8. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection.

Authors: Alena Atrasheuskaya; Peter Petzelbauer; Terry M Fredeking; George Ignatyev
Journal: FEMS Immunol Med Microbiol Date: 2003-01-21

9. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals.

Authors: Pierre-Yves Lozach; Laura Burleigh; Isabelle Staropoli; Erika Navarro-Sanchez; Julie Harriague; Jean-Louis Virelizier; Felix A Rey; Philippe Desprès; Fernando Arenzana-Seisdedos; Ali Amara
Journal: J Biol Chem Date: 2005-04-26 Impact factor: 5.157

10. Phenotypic analysis of dengue virus isolates associated with dengue fever and dengue hemorrhagic fever for cellular attachment, replication and interferon signaling ability.

Authors: Ratree Takhampunya; Dupeh R Palmer; Sasha McClain; David A Barvir; Julia Lynch; Richard G Jarman; Stephen Thomas; Robert V Gibbons; Timothy H Burgess; Peifang Sun; Edwin Kamau; Robert Putnak; Chunlin Zhang
Journal: Virus Res Date: 2009-06-21 Impact factor: 3.303

135 in total

Review 1. Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.

Authors: Rashedul Islam; Mohammed Salahuddin; Md Salahuddin Ayubi; Tahmina Hossain; Apurba Majumder; Andrew W Taylor-Robinson; Abdullah Mahmud-Al-Rafat
Journal: Virol Sin Date: 2015-10-20 Impact factor: 4.327

2. Tick-borne Encephalitis Vaccines.

Authors: Axel T Lehrer; Michael R Holbrook
Journal: J Bioterror Biodef Date: 2011

3. Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles.

Authors: Corey A Balinsky; Hana Schmeisser; Sundar Ganesan; Kavita Singh; Theodore C Pierson; Kathryn C Zoon
Journal: J Virol Date: 2013-09-11 Impact factor: 5.103

Review 4. Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials.

Authors: Aravinda M de Silva; Eva Harris
Journal: Cold Spring Harb Perspect Biol Date: 2018-06-01 Impact factor: 10.005

5. High-content assay to identify inhibitors of dengue virus infection.

Authors: David Shum; Jessica L Smith; Alec J Hirsch; Bhavneet Bhinder; Constantin Radu; David A Stein; Jay A Nelson; Klaus Früh; Hakim Djaballah
Journal: Assay Drug Dev Technol Date: 2010-10 Impact factor: 1.738

6. Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants.

Authors: Priscila M S Castanha; Cynthia Braga; Marli T Cordeiro; Ariani I Souza; Claudeir D Silva; Celina M T Martelli; Willem G van Panhuis; Eduardo J M Nascimento; Ernesto T A Marques
Journal: J Infect Dis Date: 2016-04-07 Impact factor: 5.226